FRANCK PEREZ

Doctor,
Research Director CNRS
Recherche - Paris
Spécialités / domaines
Recombinant antibodies,
Cell biology,
Cellular and Tissue Imaging,
Immunothérapie,
Multi-scale physics-chemistry-biology and cancer (molecules, cells, tissues and organisms)
Functions within Institut Curie:
Présentation

Franck Perez is Research Director at CNRS and Chairman of the "Cell Biology and Cancer" Unit of the Institut Curie in Paris. His group is studying intracellular trafficking with an important focus on the development of new methods and tools for Cell Biology studies. For example, he developed at the Institut Curie the use of automated cellular screening and co-founded a High Content screening platform (BioPhenics, with Dr. J. Camonis) directed by Elaine del Nery. In addition, his group created a novel trafficking assay and have strongly invested on the development of recombinant antibodies for cell biology. Notably, with Sandrine Moutel he developed a novel antibody library based on a humanized nanobody scaffold and created a therapeutic antibody platform.

Prior to being recruited by CNRS, F. Perez was Maître-Assistant at the University of Geneva in Switzerland, in the laboratory of Prof. T. E Kreis (1996-1999) where he worked on microtubule dynamics and intracellular trafficking. F. Perez received his PhD. in 1996 for his work in the laboratory of A. Prochiantz at the Ecole Normale Supérieure (Paris, France) on the regulation of neuroendocrine secretion and on the development of cell internalization peptides. Before his PhD., F. Perez graduated in Cell biology and Genetics at the University Paris VII.

F. Perez is an EMBO member, author of more than a hundred articles and over ten patents, and is the co-founder of three biotech companies including Honing Biosciences, spin-off from the Institut Curie which develops next generation cell-based therapies

Publications
Golgi maturation‐dependent glycoenzyme recycling controls glycosphingolipid biosynthesis and cell growth via GOLPH3
The EMBO Journal
Riccardo Rizzo, Domenico Russo, Kazuo Kurokawa, Pranoy Sahu, Bernadette Lombardi, Domenico Supino, Mikhail A Zhukovsky, Anthony Vocat, Prathyush Pothukuchi, Vidya Kunnathully, Laura Capolupo, Gaelle Boncompain, Carlo Vitagliano, Federica Zito Marino, Gabriella Aquino, Daniela Montariello, Petra Henklein, Luigi Mandrich, Gerardo Botti, Henrik Clausen, Ulla Mandel, Toshiyuki Yamaji, Kentaro Hanada, Alfredo Budillon, Franck Perez, Seetharaman Parashuraman, Yusuf A Hannun, Akihiko Nakano, Daniela Corda, Giovanni D’Angelo, Alberto Luini
High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris
European Journal of Immunology
François Anna, Sophie Goyard, Ana Ines Lalanne, Fabien Nevo, Marion Gransagne, Philippe Souque, Delphine Louis, Véronique Gillon, Isabelle Turbiez, François‐Clément Bidard, Aline Gobillion, Alexia Savignoni, Maude Guillot‐Delost, François Dejardin, Evelyne Dufour, Stéphane Petres, Odile Richard‐Le Goff, Zaineb Choucha, Olivier Helynck, Yves L. Janin, Nicolas Escriou, Pierre Charneau, Franck Perez, Thierry Rose, Olivier Lantz
Immunosuppression by Mutated Calreticulin Released from Malignant Cells
Molecular Cell
Peng Liu, Liwei Zhao, Friedemann Loos, Caroline Marty, Wei Xie, Isabelle Martins, Sylvie Lachkar, Bo Qu, Emmanuelle Waeckel-Énée, Isabelle Plo, William Vainchenker, Franck Perez, David Rodriguez, Carlos López-Otin, Peter van Endert, Laurence Zitvogel, Oliver Kepp, Guido Kroemer